Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • potatoes
    Junior Member
    • Aug 2014
    • 4

    #1

    Very simple statistic question

    If I want to know whether signal of protein X at protein Y peaks is significantly/not significant higher/lower value than random regions in the genome,

    I have 1000 peaks of protein Y with length 1000bp in mouse genome and calculate the average signal of protein X ChIP-seq at these peaks
    As control I shuffle these peaks 1000 times randomly in the genome and calculate the average signal of protein X ChIP-seq at these shuffled peaks

    Therefore I have observation table:
    Peak Signal
    Peak_A 100
    Peak_B 150
    Peak_C 50
    etc

    And shuffle table:
    Peak Signal_1 Signal_2 Signal_3 ... Signal_1000
    Peak_A 99 94 14 ... 50
    Peak_B 50 90 100 ... 25
    Peak_C 25 60 35 ... 40

    What is the best method and how to calculate p-value? Why?

    Thank you
  • potatoes
    Junior Member
    • Aug 2014
    • 4

    #2
    200 views and no one answer?

    I thought this would be an easy one... I was going to use Monte Carlo to find p-value but someone else suggested Wilcoxon, I'm just not sure which is correct

    Comment

    • dpryan
      Devon Ryan
      • Jul 2011
      • 3478

      #3
      Well, the shuffling might suffice in place of a Monte Carlo. The p-value for each peak ends up being equal to the number of shuffled peaks with greater or equal signal divided by the number of shuffled iterations. This is also how you'd get a p-value if you were to do a Monte Carlo simulation. Obviously, your p-value is limited by the number of iterations performed, so the more you do the more precise your results.

      Comment

      • potatoes
        Junior Member
        • Aug 2014
        • 4

        #4
        Originally posted by dpryan View Post
        Well, the shuffling might suffice in place of a Monte Carlo. The p-value for each peak ends up being equal to the number of shuffled peaks with greater or equal signal divided by the number of shuffled iterations. This is also how you'd get a p-value if you were to do a Monte Carlo simulation. Obviously, your p-value is limited by the number of iterations performed, so the more you do the more precise your results.
        Thank you. I agree that is how I should calculate p-value. But since I want to know at a whole whether protein X correlate with protein Y in the genome, and not which peak is significantly correlated, how should I calculate the final p value though?

        If I get p-value for each peak, I'm not sure how to convert them to a final p-value. I can't just average p-value right? Or can I make that claim if the majority of peak (e.g. 80% ) has significantly higher signal than shuffled (p < 0.05)?

        Comment

        • dpryan
          Devon Ryan
          • Jul 2011
          • 3478

          #5
          Ah, I thought you wanted per-peak p-values. I would just do the simulation then and compare the distributions of distances between peaks of the two proteins (or just bin everything and then compare bin occupancy).

          Comment

          • potatoes
            Junior Member
            • Aug 2014
            • 4

            #6
            Alright, Thank you!

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
              by SEQadmin2



              CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

              Despite this, “CRISPR helped turn genome editing from a specialized technique into
              ...
              07-31-2026, 11:01 AM
            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, Yesterday, 10:35 AM
            0 responses
            7 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-06-2026, 07:41 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 08-03-2026, 10:13 AM
            0 responses
            43 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-31-2026, 02:55 AM
            0 responses
            48 views
            0 reactions
            Last Post SEQadmin2  
            Working...